| Literature DB >> 27139478 |
Subramanya Lingaraju1, Leen Rigouts2, Aditi Gupta1, Jongseok Lee3, Alaine Nyaruhirira Umubyeyi4, Amy L Davidow5, Susan German5, EunJin Cho3, Ji-Im Lee3, Sang-Nae Cho6, Cheon Tae Kim7, David Alland1, Hassan Safi8.
Abstract
Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in Mycobacterium tuberculosis We evaluated the prevalence of ubiA and embB (Rv3795) mutations in EMB-resistant strains originating from Africa and South Korea. No differences in embB mutation frequencies were observed between strains from both origins. However, ubiA mutations were present in 45.5% ± 6.5% of the African EMB-resistant isolates but in only 9.5% ± 1.5% of the South Korean EMB-resistant isolates. The ubiA mutations associated with EMB resistance were localized to regions encoding the transmembrane domains of the protein, whereas the embB mutations were localized to regions encoding the extramembrane domains. Larger studies are needed to investigate the causes of increased ubiA mutations as a pathway to high-level EMB resistance in African countries, such as extended EMB usage during tuberculosis treatment.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27139478 PMCID: PMC4914663 DOI: 10.1128/AAC.03002-15
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191